<DOC>
	<DOCNO>NCT00107822</DOCNO>
	<brief_summary>The purpose study evaluate safety one treatment S-Caine™ Peel ( skin numb cream ) apply healthy skin painful dermatologic procedure child . This study also evaluate well S-Caine™ Peel ease pain procedure .</brief_summary>
	<brief_title>Safety Study S-Caine Peel ( Skin Numbing Cream ) Before Painful Dermatologic Procedure Children</brief_title>
	<detailed_description>The practice dermatology see rise number surgical laser procedure technological advance expand number condition amenable evolve therapy . Skin biopsy , shave excision , deep excision , electro-surgical procedure , intralesional injection , laser surgery frequently perform dermatologist daily basis . Some pain accompanies almost procedure , local anesthetic commonly use . Traditionally , intracutaneous injection lidocaine ( without epinephrine ) anesthetic choice . However , patient undergoing procedure often afraid needle syrinx pain associated injection . As result , topical anesthetic agent explore developed painless alternative inject anesthesia . S-Caine™ Peel ( lidocaine 7 % tetracaine 7 % cream ) consist new eutectic formulation lidocaine tetracaine . S-Caine Peel topical local anesthetic cream form pliable peel skin expose air . S-Caine Peel occlude application . The pain associate medical procedure often under-treated child . Children often undergo painful procedure little anesthetic , even effective therapy available . Reasons provide available therapy child include concern adverse side effect , well length time necessary provide adequate anesthesia . Recent guideline strongly advocate proactive treatment pain child , include pain associate medical procedure .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>Patient 0 17 year age . Patient require minor major dermal procedure . Patient 's legal guardian able read understand write informed consent sign date write informed consent . The patient must provide assent whenever possible . Patient known allergy , contraindication sensitivity lidocaine , tetracaine , local anesthetic amide ester type component test material . Patient know active atopic dermatitis designate treatment site . Patient damage , denude broken skin designate treatment site . Patient pregnant breastfeeding . Patient participate investigational study clinical trial unapproved drug within previous 30 day . Patient bear prematurely ( less 38 week ) . Patient enrol previous study involve SCaine Peel .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>Pain</keyword>
</DOC>